InvestorsHub Logo
Followers 369
Posts 24394
Boards Moderated 1
Alias Born 07/11/2011

Re: None

Wednesday, 09/25/2013 3:20:33 PM

Wednesday, September 25, 2013 3:20:33 PM

Post# of 2526
$ISCO >>> ISCO’s scientists are focused on using hpSC to treat severe diseases of the eye, the nervous system and the liver where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells.



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.